Healthcare - Medical - Devices - NASDAQ - US
$ 7.61
-0.262 %
$ 474 M
Market Cap
-7.69
P/E
CASH FLOW STATEMENT
-34.6 M
OPERATING CASH FLOW
-81.3 M
INVESTING CASH FLOW
109 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Treace Medical Concepts, Inc.
| Net Income | -49.5 M |
| Depreciation & Amortization | 5.35 M |
| Capital Expenditures | -11.5 M |
| Stock-Based Compensation | 17.4 M |
| Change in Working Capital | -9.74 M |
| Others | 8.23 M |
| Free Cash Flow | -46 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | |
|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||
| Net Income | (49.5) | (42.8) | (20.6) | (3.7) | (4.3) |
| Depreciation & Amortization | 5.4 | 2.1 | 0.7 | 1.2 | 0.8 |
| Deferred Income Tax | 0 | 0 | 0.4 | 2.1 | 0.1 |
| Stock Based Compensation | 17.4 | 8.1 | 3.4 | 0.9 | 0.8 |
| Other Operating Activities | 2.0 | 7.7 | 0.2 | 0.2 | 0.1 |
| Change in Working Capital | (9.7) | (5.8) | (1.3) | (5.3) | (5.3) |
| Cash From Operations | (34.6) | (30.6) | (17.2) | (4.5) | (7.7) |
| INVESTING CASH FLOW | |||||
| Capital Expenditures | (11.5) | (14.8) | (2.7) | (1.1) | (1.2) |
| Other Items | (69.8) | (61.7) | 0 | 0 | 0 |
| Cash From Investing Activities | (81.3) | (76.5) | (2.7) | (1.1) | (1.2) |
| FINANCING CASH FLOW | |||||
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Total Debt Repaid | 0 | 19.6 | 0 | 11.3 | 20.0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 1.9 | 1.2 | 107.7 | 0.2 | (0.3) |
| Cash From Financing Activities | 109.4 | 20.8 | 107.7 | 11.5 | 19.7 |
| CHANGE IN CASH | |||||
| Net Change In Cash | (6.5) | (86.4) | 87.8 | 5.9 | 10.9 |
| FREE CASH FLOW | |||||
| Free Cash Flow | (46.0) | (45.5) | (19.9) | (5.6) | (8.9) |